Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates

Mayo Clinic Proceedings

Volumn 80, Issue 11, 2005, Pages 1414-1420

  Peikert, Tobias ^a   Rana, Sameer ^a,b   Edell, Eric S ^a  

^a Mayo Clinic   (United States)

^b MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOLYTE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; FLUCONAZOLE; GLUCOCORTICOID; ITRACONAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BRONCHOSCOPE; BRONCHOSCOPY; CLINICAL ARTICLE; DEMOGRAPHY; DIAGNOSTIC VALUE; DNA VIRUS; EVALUATION; FEBRILE NEUTROPENIA; FEMALE; FLEXIBLE BRONCHOSCOPY; FUNGUS; GRAM NEGATIVE BACTERIUM; HISTOLOGY; HUMAN; IMAGE ANALYSIS; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD; MORTALITY; MYCOSIS; PNEUMONIA; RETROSPECTIVE STUDY; REVIEW; SAFETY; SPUTUM ANALYSIS; TRANSBRONCHIAL BIOPSY; UNITED STATES; VIRUS PNEUMONIA;

EID: 27644459478     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.11.1414     Document Type: Article

References (30)

1. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med. 1985;145:1621-1629.
2. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993;328:1323-1332.
3. Rossi C, Klastersky J. Initial empirical antibiotic therapy for neutropenic fever: analysis of the causes of death. Support Care Cancer. 1996;4:207-212.
4. Ozer H, Armitage JO, Bennett CL, et al, American Society of Clinical Oncology Growth Factors Expert Panel. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol. 2000;18:3558-3585.
5. Maschmeyer G, Link H, Hiddemann W, et al. Pulmonary infiltrations in febrile patients with neutropenia: risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer. 1994;73:2296-2304.
6. Rossini F, Verga M, Pioltelli P, et al. Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica. 2000;85:1255-1260.
7. Gruson D, Hilbert G, Valentino R, et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med. 2000;28:2224-2230.
8. Cordonnier C, Escudier E, Verra F, Brochard L, Bernaudin JF, Fleury-Feith J. Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern. Eur Respir J. 1994;7:114-120.
9. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391-1402.
10. Walsh TJ, Pappas P, Winston DJ, et al, National Institute of Allergy and Infectious Diseases Mycoses Study Group. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346:225-234.
11. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
12. Rein MF, Mandell GL. Bacterial killing by bacteriostatic saline solutions-potential for diagnostic error. N Engl J Med. 1973;289:794-795.
13. Ruutu P, Ruutu T, Volin L, Tukiainen P, Ukkonen P, Hovi T. Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant receipients without pneumonia. Ann Intern Med. 1990;112:913-916.
14. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004;125:712-722.
15. Paradis IL, Grgurich WF, Dummer JS, Dekker A, Dauber JH. Rapid detection of cytomegalovirus pneumonia from lung lavage cells. Am Rev Respir Dis. 1988;138:697-702.
16. Michaelides A, Liolios L, Glare EM, et al. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis. Transplantation. 2001;72:141-147.
17. Sanchez JL, Kruger RM, Paranjothi S, et al. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation. 2001;72:733-735.
18. Ascioglu S, Rex JH, de Pauw B, et al, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34;7-14.
19. Martin WJ II, Smith TF, Sanderson DR, Brutinel WM, Cockerill FR III, Douglas WW. Role of bronchoalveolar lavage in the assessment of opportunistic pulmonary infections: utility and complications. Mayo Clin Proc. 1987;62:549-557.
20. Pisani RJ, Wright AJ. Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc. 1992;67:221-227.
21. Ramila E, Sureda A, Martino R, et al. Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray. Haematologica. 2000;85:961-966.
22. Reichenberger F, Habicht J, Matt P, et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant. 1999;24:1195-1199.
23. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996;100:171-178.
24. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: results from a three-year prospective study. Am J Med. 1986;81:249-254.
25. Simpson FG, Arnold AG, Purvis A, Belfield PW, Muers MF, Cooke NJ. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax. 1986;41:311-317.
26. Hernandez Blasco L, Sanchez Hemandez IM, Villena Garrido V, de Miguel Poch E, Nunez Delgado M, Alfaro Abreu J. Safety of the transbronchial biopsy in outpatients. Chest. 1991;99:562-565.
27. Ahmad M, Livingston DR, Golish JA, Mehta AC, Wiedemann HP. The safety of outpatient transbronchial biopsy. Chest. 1986;90:403-405.
28. Papin TA, Lynch JP III, Weg JG. Transbronchial biopsy in the thrombocytopenic patient. Chest. 1985;88:549-552.
29. White P, Bonacum JT, Miller CB. Utility of fiberoptic bronchoscopy in bone marrow transplant patients. Bone Marrow Transplant. 1997;20:681-687.
30. Nucci M, Anaissie EJ, Queiroz-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003;98:315-319.